A drug that treats tumors and epilepsy in people with tuberous sclerosis complex does not boost their intelligence or ease autism traits.

People tend to believe that, regardless of the treatment, more is always better. But is it?

Watch the complete replay of Mark Bear discussing the latest research on treatments for fragile X syndrome.

Clinical trials of autism treatments rarely use a consistent set of tools to measure efficacy, making it tough to compare the treatments.

An auditory therapy may improve autistic people’s emotional control and help them feel safe enough to engage with the world.

A Utah program provides comprehensive care for autistic people across the lifespan and engages families in the decision-making.

An experimental drug that muffles the activity of neurons in the skin moderates heightened reactions to touch in six mouse models of autism.

An experimental behavioral therapy delivered by parents does not improve autism traits in babies who screen positive for the condition.

The more words autistic children hear as infants — and the more verbal interactions they have with their caregivers — the better their language skills at age 2.

Autistic people are four times as likely to experience depression over the course of their lives as their neurotypical peers. Yet researchers know little about why, or how best to help.